Robert Heft
board member
Clementia Pharmaceuticals
Canada
Biography
Dr. Robert Heft has over 30 years of experience in the biopharmaceutical industry, during which time he has held key leadership positions at a number of high-profile companies. He served as president, chief executive officer and member of the Board of Directors of Enobia Pharma Inc. (acquired by Alexion) (Montreal, Quebec) from 2005-2012. He has also held several senior positions with BioMarin Pharmaceutical Inc. after selling the pharmaceutical assets of IBEX Pharmaceuticals Inc. to BioMarin in 2001. Dr. Heft founded IBEX in 1986, and served as its President, Chief Scientist and member of its Board of Directors until 2001. He served as Executive in Residence at Sectoral Asset Management as well as on the Board of Directors of BioCapital (Private Equity/Venture Capital), the Canadian Genetic Diseases Network and the Industrial Biotechnology Association of Canada.
Research Interest
management
